TRWD 最新10-Q变化
将 TRWD 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-08-19 与上一份 10-Q · 2026-05-14
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +21 | −93 | 0 | 0 |
| 控制与程序 | 文字有新增/删除 | +9 | −92 | 0 | 0 |
| 法律诉讼 | 文字有新增/删除 | +1 | −92 | 0 | 0 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):市场风险(第3项)、风险因素、其他信息
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-08-19
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the related notes to those statements included elsewhere in this prospectus. In addition to historical financial information, the following discu…
Tradewinds Universal (“Tradewinds” or the “Company”) is a holding company focused on acquiring and developing businesses with long-term value, resilience, and growth potential. Our initial operations focused on the development and distribution of high-nutrition foods and beverages, including edible …
On August 19, 2025, we entered into a non-binding Letter of Intent with Scar Holdings LLC, also known as Peppermint Hippo(TM), regarding the potential formation of a division focused on the acquisition and development of nightlife and hospitality venues under the Peppermint Hippo brand. The first pr…
We successfully completed the development, manufacturing, and initial distribution of two protein bar SKUs (Chocolate Almond and Peanut Butter Fruit) in 2023 through our partnership with YouBar, Inc. In 2024, we entered into a purchase agreement with a distributor for 1,040 cases of UP bars, all of …
Looking ahead, we intend to keep expanding our UP product line, move forward with commercializing our canine pain relief formula, explore licensing and distribution opportunities, and evaluate opportunities in the nightlife and hospitality markets. We expect operating expenses to remain elevated as …
相对上期删除的文字 · 来源:10-Q · 2026-05-14
ITEM 3 Quantitative and Qualitative Disclosures about Market Risk 17
ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds 18
Balance Sheets as of March 31, 2026 (unaudited) and December 31, 2025 (audited) 4
Statements of Operations for the three months ended March 31, 2026 and 2025 (unaudited) 5
Statements of Stockholders' Equity for the three months ended March 31, 2026, and 2025 (unaudited) 6
控制与程序
相对上期新增的文字 · 来源:10-Q · 2026-08-19
Evaluation of Disclosure Controls and Procedures. Our principal executive officer and principal financial officer, after evaluating the effectiveness of our disclosure controls and procedures (as defined
in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q, have concluded that, based on such evaluation, our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports that…
Changes in Internal Control over Financial Reporting. There were no changes in our internal control over financial reporting, identified in connection with the evaluation of such internal control that occurred during the quarter ended June 30, 2026, that have materially affected, or are reasonably l…
Management’s Quarterly Report on Internal Control over Financial Reporting. Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act,…
● pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
相对上期删除的文字 · 来源:10-Q · 2026-05-14
ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds 18
Balance Sheets as of March 31, 2026 (unaudited) and December 31, 2025 (audited) 4
Statements of Operations for the three months ended March 31, 2026 and 2025 (unaudited) 5
Statements of Stockholders' Equity for the three months ended March 31, 2026, and 2025 (unaudited) 6
Statements of Cash Flows for the three months ended March 31, 2026 and 2025 (unaudited) 7
法律诉讼
相对上期新增的文字 · 来源:10-Q · 2026-08-19
We know of no material, existing, or pending legal proceedings against our company, nor are we involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which any of our directors, officers, or affiliates, or any registered or beneficial shareholder, is an…
相对上期删除的文字 · 来源:10-Q · 2026-05-14
ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds 18
Balance Sheets as of March 31, 2026 (unaudited) and December 31, 2025 (audited) 4
Statements of Operations for the three months ended March 31, 2026 and 2025 (unaudited) 5
Statements of Stockholders' Equity for the three months ended March 31, 2026, and 2025 (unaudited) 6
Statements of Cash Flows for the three months ended March 31, 2026 and 2025 (unaudited) 7
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议